BioVinc Receives an STTR Phase II Grant from the National Institutes of Health
BioVinc is pleased to announce that its research team has been awarded an STTR Phase II grant from the National Institutes of Health (NIH/NIDCR).
This grant will support a highly promising collaboration with Dr. Parish P. Sedghizadeh at the University of Southern California Dental School (USC) (https://dentists.usc.edu/dentists/parish-sedghizadeh/). In this effort, BioVinc will continue to pursue an accelerated path to the clinic with its novel bone-targeted antibiotic drug candidates which will potentially provide a significant improvement and less invasive approach to patient care for the treatment of bone infections.